Effect of lignocaine, sodium cromoglycate, and ipratropium bromide in exercise-induced asthma.
D000293:Adolescent; D000328:Adult; D000336:Aerosols; D001249:Asthma / Q000188:drug therapy*; D001250:Asthma, Exercise-Induced / Q000188:drug therapy* / Q000503:physiopathology; D001286:Atropine Derivatives / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use*; D008012:Lidocaine / Q000627:therapeutic use*; D008297:Male; D008450:Maximal Midexpiratory Flow Rate; D008875:Middle Aged
D000336:Aerosols; D001286:Atropine Derivatives; D008012:Lidocaine; D009241:Ipratropium; D004205:Cromolyn Sodium